Anthony Ebert

Dr. Anthony Ebert


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
AEAnthony Ebert
Anthony Ebert
SHShania Harper
Shania Harper
MVMarie V. Vestergaard
Marie V. Vestergaard
WMWayne Mitchell
Wayne Mitchell
TJTine Jess
Tine Jess
RERahma Elmahdi
Rahma Elmahdi
Infectious mononucleosis (IM) is suspected to be associated with inflammatory bowel disease (IBD) development. Using a Danish nationwide cohort of people developing severe IM and their age-, sex-, and socioeconomic (SES) index-matched counterparts, we investigated the subsequent risk of IBD, Crohn’s disease (CD), or ulcerative colitis (UC) development from 1977 to 2021. Among 39,684 severe IM patients we find a sex-, age-, and SES index-adjusted HR for IBD of 1.35 (95% CI: 1.22–1.49). This significantly increased risk was seen for both CD (HR: 1.56; 95% CI: 1.34–1.83) and to a lesser extent UC (HR: 1.23; 95% CI: 1.08–1.40) and remains following negative control matching with a cohort diagnosed with Chlamydia trachomatis infection (HR: 1.39; 95% CI: 1.01–1.91). Those with severe IM at 0–9 years had a particularly increased risk for CD (HR: 1.77; 95% CI: 1.26–2.49). Here we show an increased risk for IBD diagnosis following IM hospitalisation, indicating an association between severe EBV disease and later IBD development. Further exploration of the potential factors contributing to IBD susceptibility following EBV disease is warranted.

1 October 2020
Verified
Journal Article
Closed access
AEAnthony Ebert
Anthony Ebert
PWPaul Wu
Paul Wu
KMKerrie Mengersen
Kerrie Mengersen
FRFabrizio Ruggeri
Fabrizio Ruggeri

1 December 2010 in Chemical Engineering Journal
Verified
Journal Article
Closed access
JLJun Liu
Jun Liu
AEAnthony Ebert
Anthony Ebert
MVMeherzad F. Variava
Meherzad F. Variava
Fariba DehghaniFariba Dehghani
Fariba Dehghani
AHAndrew T. Harris
Andrew T. Harris

30 July 2025 in American Journal of Gastroenterology
Verified
Journal Article
Open access
AEAnthony Ebert
Anthony Ebert
BVBram Verstockt
Bram Verstockt
MBMartin Bøgsted
Martin Bøgsted
LLLone Larsen
Lone Larsen
GPGry Poulsen
Gry Poulsen
TJTine Jess
Tine Jess
INTRODUCTION: Inflammatory bowel disease (IBD) is associated with various extraintestinal manifestations. We aimed to identify comorbidities in IBD and the timing of their development to provide potentially useful insight into the associations with IBD. METHODS: We conducted a population and disease-wide phenomic association study in IBD, using >6 million International Classification of Diseases, Tenth Revision coded healthcare contacts from 10 years before and up-to 17 years after IBD diagnosis to investigate associations with 1,583 comorbidities. To explore diseases with potential etiological significance, we compared association in the prediagnostic and the postdiagnostic periods. We corrected also for multiple-testing. These estimates were validated with publicly available data from Finland. RESULTS: We identified 312 significant associations with 125 appearing before diagnosis. Risk of extraintestinal manifestations was increased up to 10 years before IBD diagnosis, such as psoriasis (OR CD : 2.58 95% confidence interval: [2.00–3.31]; OR UC : 1.54 [1.26–1.88]) and reactive arthropathies (OR CD : 2.07 [1.42–2.96]; OR UC : 1.42 [1.08–1.84]). Risk of cardiometabolic and neuropsychological disorders was increased both prediagnostically and postdiagnostically. Potential treatment sequelae, such as osteoporosis (HR CD : 2.56 [2.30–2.86]; HR UC : 1.92 [1.79–2.07]) were primarily seen postdiagnostically. In only 15.7% (44/281) and 11.4% (35/301) of comorbidities in Crohn's disease and ulcerative colitis, respectively, did we observe heterogeneity between Denmark and Finland. DISCUSSION: Findings demonstrate that IBD is a multisystemic disease, particularly manifesting with metabolic, immune, and neuropsychological disorders, up to 10 years before diagnosis. We find evidence for the generality of these findings with an international comparison. Diseases of etiological interest warrant further investigation.

5 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
DWDavid J. Warne
David J. Warne
AEAnthony Ebert
Anthony Ebert
CDChristopher Drovandi
Christopher Drovandi
WHWenbiao Hu
Wenbiao Hu
AMAntonietta Mira
Antonietta Mira
KMKerrie Mengersen
Kerrie Mengersen
Background: The global impact of COVID-19 and the country-specific responses to the pandemic provide an unparalleled opportunity to learn about different patterns of the outbreak and interventions. We model the global pattern of trajectories of reported COVID-19 cases during the primary response period, with the aim of learning from the past to prepare for the future. Methods: Using Bayesian methods, we analyse the response to the COVID-19 outbreak for 158 countries for the period 22 January to 9 June 2020. This encompasses the period in which many countries imposed a variety of response measures and initial relaxation strategies. Instead of modelling specific intervention types and timings for each country explicitly, we adopt a stochastic epidemiological model including a feedback mechanism on virus transmission to capture complex nonlinear dynamics arising from continuous changes in community behaviour in response to rising case numbers. We analyse the overall effect of interventions and community responses across diverse regions. This approach mitigates explicit consideration of issues such as period of infectivity and public adherence to government restrictions. Results: Countries with the largest cumulative case tallies are characterised by a delayed response, whereas countries that avoid substantial community transmission during the period of study responded quickly. Countries that recovered rapidly also have a higher case identification rate and small numbers of undocumented community transmission at the early stages of the outbreak. We also demonstrate that uncertainty in numbers of undocumented infections dramatically impacts the risk of second waves. Our approach is also effective at pre-empting potential second waves and flare-ups. Conclusions: We demonstrate the utility of modelling to interpret community behaviour in the early epidemic stages. Two lessons learnt that are important for the future are: i) countries that imposed strict containment measures early in the epidemic fared better with respect to numbers of reported cases; and ii) broader testing is required early in the epidemic to understand the magnitude of undocumented infections and recover rapidly. We conclude that clear patterns of containment are essential prior to relaxation of restrictions and show that modelling can provide insights to this end.

15 February 2024 in medRxiv
Verified
Preprint
Open access
PDF file
AEAnthony Ebert
Anthony Ebert
RERahma Elmahdi
Rahma Elmahdi
BVBram Verstockt
Bram Verstockt
MBMartin Bøgsted
Martin Bøgsted
GPGry Poulsen
Gry Poulsen
TJTine Jess
Tine Jess
Introduction: Inflammatory bowel disease (IBD) is associated with various extra-intestinal manifestations. We aim to identify comorbidities in IBD and the timing of their development to provide valuable insight into the mechanisms under-lying IBD. Methods: We conducted a population– and disease-wide phenomic association study in IBD, using > 6 million ICD-10 coded healthcare contacts from 10 years before and up-to 17 years after IBD diagnosis to investigate associations with 1583 comorbidities. To explore diseases with potential aetiological significance, we compared association in the pre-diagnostic and the post-diagnostic periods. We corrected also for multiple-testing. These estimates were validated with publically available data from Finland. Results: We identified 312 significant associations with 125 appearing before diagnosis. Risk of immune-mediated diseases and extra-intestinal manifestations was increased up to 10 years prior to IBD diagnosis, such as psoriasis (OR CD : 2.58 95% CI: [2.00-3.31]; OR UC : 1.54 [1.26-1.88]) and reactive arthropathies (OR CD : 2.07 [1.42-2.96]; OR UC : 1.42 [1.08-1.84]). Risk of cardiometabolic and neuropsychological disorders was increased both pre– and post-diagnostically. Potential treatment sequelae, such as osteoporosis (HR CD : 2.56 [2.30-2.86]; HR UC : 1.92 [1.79-2.07]) were primarily seen post-diagnostically. In only 15.7% (44/281) and 11.4% (35/301) of comorbidities in CD and UC respectively did we observe heterogeneity between Denmark and Finland. Conclusion: Findings demonstrate that IBD is a multisystemic disease, particularly manifesting with metabolic, im-mune, and neuropsychological disorders, up-to 10 years prior to diagnosis. We find evidence for the generality of these findings with an international comparison. Diseases of etiological interest warrant further investigation. STUDY HIGHLIGHTS: WHAT IS KNOWN: IBD is strongly associated with other diseases IBD has a complex etiology WHAT IS NEW HERE: IBD appears to be a multiorgan systemic disease not confined to the gut Associations between IBD and non-digestive disorders are present up to 10 years prior to diagnosis either reflecting a prolonged pre-diagnostic phase or common etiologies These findings are validated in an international comparison